Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Liver Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06093230
What this trial is testing

A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function

Who this might be right for
Subjects With Liver Function InjuryNormal Liver Function Subject
Shanghai Vinnerna Biosciences Co., Ltd. 24
Early research (Phase 1)Study completedNCT01271387
What this trial is testing

Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment

Who this might be right for
Hepatic Impairment
Vanda Pharmaceuticals 29
Early research (Phase 1)Study completedNCT04634149
What this trial is testing

Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Who this might be right for
Moderate Liver ImpairmentSevere Liver Impairment
Bristol-Myers Squibb 16
Early research (Phase 1)Study completedNCT04406896
What this trial is testing

The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics

Who this might be right for
Healthy SubjectsHepatic Impairment
Viatris Innovation GmbH 24
Early research (Phase 1)Looking for participantsNCT07231991
What this trial is testing

Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function

Who this might be right for
Healthy Participants
Pfizer 24
Early research (Phase 1)UnknownNCT05151705
What this trial is testing

A Trial of HR17031 Injection With Hepatic Insufficiency

Who this might be right for
Improved Glycemic Control in Patients With Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)Study completedNCT04867941
What this trial is testing

Evaluate the Effect of Hepatic Insufficiency on the Pharmacokinetics (PK) of ACP-196

Who this might be right for
Hepatic Insufficiency
Acerta Pharma BV 18
Post-approval studies (Phase 4)Study completedNCT04349696
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)

Who this might be right for
Type 2 Diabetes MellitusLiver Dysfunction
Orient Europharma Co., Ltd. 16
Early research (Phase 1)Ended earlyNCT04241835
What this trial is testing

Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function

Who this might be right for
Hepatic ImpairmentAdvanced Malignant Solid Tumor
Epizyme, Inc. 18
Post-approval studies (Phase 4)Study completedNCT01767103
What this trial is testing

An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers

Who this might be right for
Hepatic Impairment
ApoPharma 21
Early research (Phase 1)Study completedNCT06888115
What this trial is testing

The Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

Who this might be right for
Primary Biliary Cholangitis
Cascade Pharmaceuticals, Inc 24
Early research (Phase 1)Study completedNCT01531309
What this trial is testing

Pharmacokinetics of AGO178 in Participants With Liver Impairment

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT04293029
What this trial is testing

Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)Active Not RecruitingNCT07168356
What this trial is testing

Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

Who this might be right for
Hepatitis B
GlaxoSmithKline 32
Early research (Phase 1)Looking for participantsNCT07559474
What this trial is testing

Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Who this might be right for
Hepatic InsufficiencyLiver Diseases
Incyte Corporation 16
Early research (Phase 1)Ended earlyNCT00004239
What this trial is testing

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Alliance for Clinical Trials in Oncology 10
Testing effectiveness (Phase 2)Study completedNCT01830127
What this trial is testing

BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 35
Early research (Phase 1)Study completedNCT06812780
What this trial is testing

Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD2389

Who this might be right for
Hepatic Impairment
AstraZeneca 35
Early research (Phase 1)Study completedNCT05718258
What this trial is testing

A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic Function

Who this might be right for
Hepatic Function Abnormal
Sanofi 26
Early research (Phase 1)Study completedNCT02161770
What this trial is testing

Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment

Who this might be right for
Solid Tumours
AstraZeneca 30
Next Page